112 related articles for article (PubMed ID: 18272366)
1. Synthesis and in vitro activity of 1-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-1H-1,2,4-triazol-5-amine and 4-(2,3-dichlorophenyl)-N-(pyridin-3-ylmethyl)-4H-1,2,4-triazol-3-amine P2X7 antagonists.
Florjancic AS; Peddi S; Perez-Medrano A; Li B; Namovic MT; Grayson G; Donnelly-Roberts DL; Jarvis MF; Carroll WA
Bioorg Med Chem Lett; 2008 Mar; 18(6):2089-92. PubMed ID: 18272366
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro activity of N'-cyano-4-(2-phenylacetyl)-N-o-tolylpiperazine-1-carboximidamide P2X7 antagonists.
Morytko MJ; Betschmann P; Woller K; Ericsson A; Chen H; Donnelly-Roberts DL; Namovic MT; Jarvis MF; Carroll WA; Rafferty P
Bioorg Med Chem Lett; 2008 Mar; 18(6):2093-6. PubMed ID: 18272365
[TBL] [Abstract][Full Text] [Related]
3. Novel and potent 3-(2,3-dichlorophenyl)-4-(benzyl)-4H-1,2,4-triazole P2X7 antagonists.
Carroll WA; Kalvin DM; Perez Medrano A; Florjancic AS; Wang Y; Donnelly-Roberts DL; Namovic MT; Grayson G; Honoré P; Jarvis MF
Bioorg Med Chem Lett; 2007 Jul; 17(14):4044-8. PubMed ID: 17482819
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro activity of N-benzyl-1-(2,3-dichlorophenyl)-1H-tetrazol-5-amine P2X(7) antagonists.
Perez-Medrano A; Donnelly-Roberts DL; Florjancic AS; Nelson DW; Li T; Namovic MT; Peddi S; Faltynek CR; Jarvis MF; Carroll WA
Bioorg Med Chem Lett; 2011 Jun; 21(11):3297-300. PubMed ID: 21536435
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of a series of (1H-pyrazol-4-yl)acetamide antagonists of the P2X7 receptor.
Chambers LJ; Stevens AJ; Moses AP; Michel AD; Walter DS; Davies DJ; Livermore DG; Fonfria E; Demont EH; Vimal M; Theobald PJ; Beswick PJ; Gleave RJ; Roman SA; Senger S
Bioorg Med Chem Lett; 2010 May; 20(10):3161-4. PubMed ID: 20399651
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship studies on a series of novel, substituted 1-benzyl-5-phenyltetrazole P2X7 antagonists.
Nelson DW; Gregg RJ; Kort ME; Perez-Medrano A; Voight EA; Wang Y; Grayson G; Namovic MT; Donnelly-Roberts DL; Niforatos W; Honore P; Jarvis MF; Faltynek CR; Carroll WA
J Med Chem; 2006 Jun; 49(12):3659-66. PubMed ID: 16759108
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and activity of N-cyanoguanidine-piperazine P2X7 antagonists.
Betschmann P; Bettencourt B; Donnelly-Roberts D; Friedman M; George J; Hirst G; Josephsohn N; Konopacki D; Li B; Maull J; Morytko MJ; Moore NS; Namovic M; Rafferty P; Salmeron-Garcia JA; Tarcsa E; Wang L; Woller K
Bioorg Med Chem Lett; 2008 Jul; 18(14):3848-51. PubMed ID: 18595695
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship studies on N'-aryl carbohydrazide P2X7 antagonists.
Nelson DW; Sarris K; Kalvin DM; Namovic MT; Grayson G; Donnelly-Roberts DL; Harris R; Honore P; Jarvis MF; Faltynek CR; Carroll WA
J Med Chem; 2008 May; 51(10):3030-4. PubMed ID: 18438986
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of a series of tetrasubstituted-imidazoles as P2X(7) antagonists.
Gleave RJ; Walter DS; Beswick PJ; Fonfria E; Michel AD; Roman SA; Tang SP
Bioorg Med Chem Lett; 2010 Aug; 20(16):4951-4. PubMed ID: 20634071
[TBL] [Abstract][Full Text] [Related]
10. Rational design, synthesis, and structure-activity relationships of aryltriazoles as novel corticotropin-releasing factor-1 receptor antagonists.
Lowe RF; Nelson J; Dang TN; Crowe PD; Pahuja A; McCarthy JR; Grigoriadis DE; Conlon P; Saunders J; Chen C; Szabo T; Chen TK; Bozigian H
J Med Chem; 2005 Mar; 48(5):1540-9. PubMed ID: 15743196
[TBL] [Abstract][Full Text] [Related]
11. Part II: piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.
Parlow JJ; Burney MW; Case BL; Girard TJ; Hall KA; Harris PK; Hiebsch RR; Huff RM; Lachance RM; Mischke DA; Rapp SR; Woerndle RS; Ennis MD
Bioorg Med Chem Lett; 2010 Feb; 20(4):1388-94. PubMed ID: 20097563
[TBL] [Abstract][Full Text] [Related]
12. Discovery of potent and selective adamantane-based small-molecule P2X(7) receptor antagonists/interleukin-1beta inhibitors.
Furber M; Alcaraz L; Bent JE; Beyerbach A; Bowers K; Braddock M; Caffrey MV; Cladingboel D; Collington J; Donald DK; Fagura M; Ince F; Kinchin EC; Laurent C; Lawson M; Luker TJ; Mortimore MM; Pimm AD; Riley RJ; Roberts N; Robertson M; Theaker J; Thorne PV; Weaver R; Webborn P; Willis P
J Med Chem; 2007 Nov; 50(24):5882-5. PubMed ID: 17963373
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and SAR of novel 4,5-diarylimidazolines as potent P2X7 receptor antagonists.
Merriman GH; Ma L; Shum P; McGarry D; Volz F; Sabol JS; Gross A; Zhao Z; Rampe D; Wang L; Wirtz-Brugger F; Harris BA; Macdonald D
Bioorg Med Chem Lett; 2005 Jan; 15(2):435-8. PubMed ID: 15603968
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of analogues of NF449 confirm NF449 as the most potent and selective known P2X1 receptor antagonist.
Kassack MU; Braun K; Ganso M; Ullmann H; Nickel P; Böing B; Müller G; Lambrecht G
Eur J Med Chem; 2004 Apr; 39(4):345-57. PubMed ID: 15072843
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment. 12. Structure-activity relationships associated with 4-fluoro-6-azaindole derivatives leading to the identification of 1-(4-benzoylpiperazin-1-yl)-2-(4-fluoro-7-[1,2,3]triazol-1-yl-1h-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-585248).
Regueiro-Ren A; Xue QM; Swidorski JJ; Gong YF; Mathew M; Parker DD; Yang Z; Eggers B; D'Arienzo C; Sun Y; Malinowski J; Gao Q; Wu D; Langley DR; Colonno RJ; Chien C; Grasela DM; Zheng M; Lin PF; Meanwell NA; Kadow JF
J Med Chem; 2013 Feb; 56(4):1656-69. PubMed ID: 23360431
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and SAR studies of biaryloxy-substituted triazoles as antifungal agents.
Liu P; Zhu S; Li P; Xie W; Jin Y; Sun Q; Wu Q; Sun P; Zhang Y; Yang X; Jiang Y; Zhang D
Bioorg Med Chem Lett; 2008 Jun; 18(11):3261-5. PubMed ID: 18467095
[TBL] [Abstract][Full Text] [Related]
17. Identification of 2-(4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-3-yl)-ethylamine derivatives as novel GnRH receptor antagonists.
Chen M; Guo Z; Lanier MC; Zhao L; Betz SF; Huang CQ; Loweth CJ; Ashweek NJ; Liu XJ; Struthers RS; Bradbury MJ; Behan JW; Wen J; O'Brien Z; Saunders J; Zhu YF
Bioorg Med Chem Lett; 2007 Jul; 17(14):3845-50. PubMed ID: 17521908
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationships of pyrazolodiazepine derivatives as human P2X7 receptor antagonists.
Lee JY; Yu J; Cho WJ; Ko H; Kim YC
Bioorg Med Chem Lett; 2009 Nov; 19(21):6053-8. PubMed ID: 19800793
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of some new 1,3,4-thiadiazol-2-ylmethyl-1,2,4-triazole derivatives and investigation of their antimicrobial activities.
Demirbas A; Sahin D; Demirbas N; Karaoglu SA
Eur J Med Chem; 2009 Jul; 44(7):2896-903. PubMed ID: 19167136
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vivo evaluation of [11C]SN003 as a PET ligand for CRF1 receptors.
Kumar JS; Majo VJ; Sullivan GM; Prabhakaran J; Simpson NR; Van Heertum RL; Mann JJ; Parsey RV
Bioorg Med Chem; 2006 Jun; 14(12):4029-34. PubMed ID: 16529935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
